Market Research Logo

EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026

EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026

Summary

Sepsis is a life-threatening complication arising from an infection, which occurs when the body’s response to the infection damages its own tissues and organs. Sepsis can lead to multiple organ failure and death, especially if it is not recognized early and treated promptly (Elfeky et al., 2017; Mayo Clinic, 2016). Anyone can develop sepsis; however, the condition is more common among children less than one year of age, older adults, and those with weakened immune systems (Elfeky et al., 2017; Mayo Clinic, 2016).

In men and women, among the 7MM in 2016, the US had the highest age-standardized diagnosed incidence of sepsis and Japan had the lowest. In the 5EU (France, Germany, Italy, Spain, UK), the age-standardized diagnosed incidence of sepsis in men ranged between 94.91 cases per 100,000 population in France and 174.05 cases per 100,000 population in the UK in 2016. The age-standardized diagnosed incidence of sepsis in women in the 5EU ranged between 36.76 cases per 100,000 population in France and 128.05 cases per 100,000 populations in the UK in 2016. Due to data scarcity, the crude diagnosed incidence of sepsis for Italy is considered to be same as that of Spain and therefore the calculated age-standardized diagnosed incidence rates are also similar in these markets.

Among the 7MM, in men and women in 2016, the US had the highest age-standardized diagnosed incidence of septic shock and Japan had the lowest. In the 5EU, the age-standardized diagnosed incidence of sepsis in men ranged between 29.55 cases per 100,000 population in Germany and 52.57 cases per 100,000 population in the UK in 2016. Similarly, the age-standardized diagnosed incidence of septic shock in women in the 5EU ranged between 11.56 cases per 100,000 population in France and 38.86 cases per 100,000 population in the UK in 2016. Due to data scarcity, the crude diagnosed incidence of septic shock for Italy is considered to be same as that of Spain and therefore, the calculated age-standardized diagnosed incidence rates are also similar in these markets.

The report EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026, provides an overview of the risk factors, comorbidities, and the global and historical trends for sepsis and septic shock in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report includes a 10-year epidemiological forecast for the diagnosed incident cases of sepsis and septic shock, segmented by sex and by age (for all ages).

In depth, this report provides the following -

  • The sepsis and septic shock epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Scope
  • The Sepsis and Septic Shock EpiCast Report provides an overview of the risk factors and global trends of sepsis and septic shock in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of sepsis and septic shock, segmented by age (for all ages) and sex. The sepsis and septic shock diagnosed incident cases are further segmented by causative agent and organ dysfunction. Additionally, GlobalData epidemiologists provide a forecast for the in-hospital mortality cases of sepsis and septic shock, segmented by age for both sexes.
  • The sepsis and septic shock epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Reasons to buy

The Sepsis and Septic Shock EpiCast report will allow you to -
  • Develop business strategies by understanding the trends shaping and driving the global sepsis and septic shock market.
  • Quantify patient populations in the global sepsis and septic shock market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for sepsis and septic shock therapeutics in each of the markets covered.
  • Understand the causative agent, organ dysfunction, and mortality of sepsis and septic shock.


1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Executive Summary 5
2.1 Related Reports 7
2.2 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.3 Global and Historical Trends 11
3.4 Forecast Methodology 13
3.4.1 Sources 13
3.4.2 Forecast Assumptions and Methods 21
3.4.3 Diagnosed Incident Cases of Sepsis 21
3.4.4 Diagnosed Incident Cases of Septic Shock 24
3.4.5 Diagnosed Incident Cases of Sepsis/Septic Shock by Causative Agent 26
3.4.6 Organ Dysfunction among Diagnosed Incident Cases of Sepsis 29
3.4.7 Organ Dysfunction among Diagnosed Incident Cases of Septic Shock 31
3.4.8 Sepsis In-Hospital Mortality Cases 33
3.4.9 Septic Shock In-Hospital Mortality Cases 36
3.5 Epidemiological Forecast for Sepsis and Septic Shock (2016-2026) 38
3.5.1 Diagnosed Incident Cases of Sepsis 38
3.5.2 Age-Specific Diagnosed Incident Cases of Sepsis 39
3.5.3 Sex-Specific Diagnosed Incident Cases of Sepsis 40
3.5.4 Diagnosed Incident Cases of Sepsis by Causative Agent 41
3.5.5 Organ Dysfunction among Diagnosed Incident Cases of Sepsis 42
3.5.6 Sepsis In-Hospital Mortality Cases 43
3.5.7 Age-Specific In-Hospital Mortality Cases of Sepsis 44
3.5.8 Diagnosed Incident Cases of Septic Shock 45
3.5.9 Age-Specific Diagnosed Incident Cases of Septic Shock 46
3.5.10 Sex-Specific Diagnosed Incident Cases of Septic Shock 47
3.5.11 Diagnosed Incident Cases of Septic Shock by Causative Agent 48
3.5.12 Organ Dysfunction among Diagnosed Incident Cases of Septic Shock 49
3.5.13 Septic Shock In-Hospital Mortality Cases 50
3.5.14 Age-Specific In-Hospital Mortality Cases of Septic Shock 51
3.6 Discussion 52
3.6.1 Epidemiological Forecast Insight 52
3.6.2 Limitations of Analysis 53
3.6.3 Strengths of Analysis 53
4 Appendix 55
4.1 Bibliography 55
4.2 About the Authors 59
4.2.1 Epidemiologist 59
4.2.2 Reviewers 59
4.2.3 Global Director of Therapy Analysis and Epidemiology 60
4.2.4 Global Head and EVP of Healthcare Operations and Strategy 60
4.3 About GlobalData 61
4.4 Contact Us 61
4.5 Disclaimer 61
1.1 List of Tables
Table 1: Risk Factors and Comorbidities for Sepsis and Septic Shock 10
Table 2: 7MM, Diagnosed Incident Cases of Sepsis, Both Sexes, All Ages, Selected Years 2016-2026 38
Table 3: 7MM, Sepsis In-Hospital Mortality Cases, Both Sexes, All Ages, Selected Years 2016-2026 43
Table 4: 7MM, Diagnosed Incident Cases of Septic Shock, Both Sexes, All Ages, Selected Years 2016-2026 45
Table 5: 7MM, Septic Shock In-Hospital Mortality Cases, Both Sexes, All Ages, Selected Years 2016-2026 50
1.2 List of Figures
Figure 1: 7MM, Diagnosed Incident Cases of Sepsis, Both Sexes, All Ages, 2016 and 2026 6
Figure 2: 7MM, Diagnosed Incident Cases of Septic Shock, Both Sexes, All Ages, 2016 and 2026 7
Figure 3: 7MM, Age-Standardized Diagnosed Incidence of Sepsis (Cases per 100,000 Population), Both Sexes, All Ages, 2016 12
Figure 4: 7MM, Age-Standardized Diagnosed Incidence of Septic Shock (Cases per 100,000 Population), Both Sexes, All Ages, 2016 13
Figure 5: 7MM, Sources Used and Not Used, Diagnosed Incident Cases of Sepsis 15
Figure 6: 7MM, Sources Used and Not Used, Diagnosed Incident Cases of Sepsis/Septic Shock by Causative Agent 16
Figure 7: 7MM, Sources Used and Not Used, Organ Dysfunction among Sepsis Cases 17
Figure 8: 7MM, Sources Used and Not Used, In-Hospital Mortality Cases of Sepsis 18
Figure 9: 7MM, Sources Used and Not Used, Diagnosed Incident Cases of Septic Shock 19
Figure 10: 7MM, Sources Used and Not Used, Organ Dysfunction of Septic Shock Cases 20
Figure 11: 7MM, Sources Used, In-Hospital Mortality Cases of Septic Shock 21
Figure 12: 7MM, Age-Specific Diagnosed Incident Cases of Sepsis, Both Sexes, All Ages, 2016 39
Figure 13: 7MM, Sex-Specific Diagnosed Incident Cases of Sepsis, Both Sexes, All Ages, 2016 40
Figure 14: 7MM, Diagnosed Incident Cases of Sepsis by Causative Agent, Both Sexes, All Ages, 2016 41
Figure 15: 7MM, Organ Dysfunction among Diagnosed Incident Cases of Sepsis, Both Sexes, All Ages, 2016 42
Figure 16: 7MM, Age-Specific In-Hospital Mortality Cases of Sepsis, Both Sexes, All Ages, 2016 44
Figure 17: 7MM, Age-Specific Diagnosed Incident Cases of Septic Shock, Both Sexes, All Ages, 2016 46
Figure 18: 7MM, Sex-Specific Diagnosed Incident Cases of Septic Shock, Both Sexes, All Ages, 2016 47
Figure 19: 7MM, Diagnosed Incident Cases of Septic Shock by Causative Agent, Both Sexes, All Ages, 2016 48
Figure 20: 7MM, Organ Dysfunction among Diagnosed Incident Cases of Septic Shock, Both Sexes, All Ages, 2016 49
Figure 21: 7MM, Age-Specific In-Hospital Mortality Cases of Septic Shock, Both Sexes, All Ages, 2016 51

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report